Borne Identity: Leading Endogenous Suspects at Imidazoline Binding Sites

作者: Haya Abu Ghazaleh , Robin J Tyacke , Alan L Hudson

DOI: 10.21767/2171-6625.100011

关键词:

摘要: Over the past few years, a vast amount of research has shed light on pharmacology imidazoline binding sites (I-BS). To date, at least three classes have been characterised in accordance to their localisation, drug selectivity, proposed signalling pathways and functional roles. The existence these raises question as whether an endogenous modulator exists. identification extract denoted clonidine displacing substance prompted search for active ingredient capable mimicking action selective ligands sites. A number candidates isolated activities assessed Such include agmatine, imidazoleacetic acid ribotide β-carboline harmane. As yet, no consensus made confirm identity ligand I-BS. current review collates reports what is known about substances significance

参考文章(107)
G.J. Molderings, K. Schmidt, H. B�nisch, M. �thert, Inhibition of 5-HT3 receptor function by imidazolines in mouse neuroblastoma cells: potential involvement of sigma 2 binding sites. Naunyn-schmiedebergs Archives of Pharmacology. ,vol. 354, pp. 245- 252 ,(1996) , 10.1007/BF00171054
MARK J. DUNNE, ELIZABETH A. HARDING, JONATHAN H. JAGGAR, PAUL E. SQUIRES, RIXIN LIANG, CHARLOTTE KANE, ROGER F. L. JAMES, NICHOLAS J. M. LONDON, Potassium channels, imidazolines, and insulin-secreting cells. Annals of the New York Academy of Sciences. ,vol. 763, pp. 243- 261 ,(1995) , 10.1111/J.1749-6632.1995.TB32410.X
Sophia Diamant, Daphne Atlas, An endogenous brain substance, CDS (clonidine-displacing-substance), inhibits the twitch response of rat vas deferens Biochemical and Biophysical Research Communications. ,vol. 134, pp. 184- 190 ,(1986) , 10.1016/0006-291X(86)90545-0
AL Hudson, RJ Tyacke, MD Lalies, N Davies, DP Finn, O Marti, E Robinson, S Husbands, MCW Minchin, A Kimura, DJ Nutt, Novel Ligands for the Investigation of Imidazoline Receptors and Their Binding Proteins Annals of the New York Academy of Sciences. ,vol. 1009, pp. 302- 308 ,(2003) , 10.1196/ANNALS.1304.039
PAUL ERNSBERGER, MARILYN E. GRAVES, LYNETTE M. GRAFF, NASSER ZAKIEH, PHONG NGUYEN, LAURA A. COLLINS, KELLY L. WESTBROOKS, GUINIVERE G. JOHNSON, I1‐Imidazoline Receptors Annals of the New York Academy of Sciences. ,vol. 763, pp. 22- 42 ,(1995) , 10.1111/J.1749-6632.1995.TB32388.X
J E Piletz, P Ernsberger, D N Chikkala, Comparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and alpha-2 adrenergic receptors. Journal of Pharmacology and Experimental Therapeutics. ,vol. 272, pp. 581- 587 ,(1995)
J. K. MA, Effect of postmortem delay on imidazoline receptor-binding proteins in human and mouse brain. Annals of the New York Academy of Sciences. ,vol. 1009, pp. 341- 346 ,(2003) , 10.1196/ANNALS.1304.043
Manish Manohar Aglawe, Brijesh Gulabrao Taksande, Sharvari Shambabu Kuldhariya, Chandrabhan Tukaram Chopde, Milind Janrao Umekar, Nandkishor Ramdas Kotagale, Participation of central imidazoline binding sites in antinociceptive effect of ethanol and nicotine in rats. Fundamental & Clinical Pharmacology. ,vol. 28, pp. 284- 293 ,(2014) , 10.1111/FCP.12034